Letter: rising incidence and poor survival in patients with non‐viral <scp>HCC</scp> – better <scp>HCC</scp> surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed. Authors' reply-Reference-Cited by-同舟云学术

Letter: rising incidence and poor survival in patients with non‐viral HCC – better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed. Authors' reply

Published:2023-01-15 Issue:3 Volume:57 Page:363-364
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Toyoda Hidenori¹^ORCID,Kariyama Kazuya²,Hiraoka Atsushi³

Affiliation:

1. Department of Gastroenterology Ogaki Municipal Hospital Ogaki Japan

2. Department of Hepatology Okayama City Hospital Okayama Japan

3. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan

Abstract

LINKED CONTENTThis article is linked to Toyoda et al papers. To view these articles, visit https://doi.org/10.1111//apt.17088 and https://doi.org/10.1111/apt.17334

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17361

Reference6 articles.

1. Letter: rising incidence and poor survival in patients with nonviral HCC–better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed;Manikat R;Aliment Pharmacol Ther,2023

2. Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan

3. ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

4. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

5. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study